Organovo Holdings, Inc. (ONVO)

[thewind]

I agree with most of your assessment. We have not seen one piece of news in relation to more customers or revenue streams. Eerily quiet...Maybe to let big dogs load up?? Or get out?? Lol!!!

As far as the new CEO getting paid less... Crouch doesn't have intimate knowledge base on the product. Limited individuals do. Anyone that does is probably in direct competition in a privately held company. Poaching them would cost way more then what it's worth. Hence Murphy taking the hefty cut on consulting. His baby too so...

What you do care about, and the current bag holders in general, is the company making money to side step dilution keeping share price.

Seems the new guy has been working within the phase of testing the product is heading into for awhile. The movement towards him was logical. Successfully putting pride aside achieved. Greed of getting "theirs" is always apparent however.

I wouldn't expect less. I believe ramping up revenue is what the change is for. Especially if they want to sell. The deferred earnings on the "validation studies" will make the guy look good out of the gate.

How is that for speculation, hope, and chatter?